We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Argent Biopharma Limited | LSE:RGT | London | Ordinary Share | AU0000326647 | ORD NPV (DI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-1.00 | -4.55% | 21.00 | 20.00 | 22.00 | 21.00 | 21.00 | 21.00 | 461 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMRGT ReGen Purchases Filtration Unit in anticipation of Increased Demand for its Nutraceutical Product - Colostrinin(TM) 29 July 2010 ReGen Therapeutics Plc ('ReGen' or the 'Company') <AIM:RGT> announces that it has recently ordered a custom made filtration unit for use in the production of its nutraceutical product Colostrinin(TM). Previously ReGen has hired this equipment, which is used for a key stage in its proprietary Colostrinin(TM) production process, performed by its contract manufacturer Sterling Technology Inc., in Brookings, South Dakota, USA. Some of the monies raised during the summer were to fund this important and vital addition to the Company's assets. When ReGen had only one major customer to service, hiring such equipment was the prudent thing to do. With the recent signing of new licensees in Turkey and India and anticipated developments in other markets ReGen believes that now is the time to invest in dedicated equipment so that we are best placed to service our current and future customers. Colostrinin(TM) is a nutritional supplement to 'support healthy brain ageing and cognition in humans'. It is marketed as a nutritional supplement in the US, Canada, Australia and Poland under the brand name CogniSure(TM) *, in Cyprus under the brand name Cognase(TM) ** and in the UK under the brand name MemoryAid***. Colostrinin(TM) is now in the process of being launched as Dyna(TM) in the Republic of Turkey by Eczacibasi and as Cognate (TM) by USV Limited in India. *CogniSure(TM) for use as a human nutraceutical is licensed in North America and Australasia to Metagenics Inc. of San Clemente, California (http://www.metagenics.com/). CogniSure(TM) is distributed in Poland by Tagerr Polska, an affiliate of Tagerr a professional services and trading company established in Köln, Germany. (http://www.cognisure.eu/) ** Cognase(TM) is distributed in the Republic of Cyprus by Golgi Pharmaceuticals Ltd (http://www.healthybrainaging.com/). *** MemoryAid is distributed in the UK by PRG Nutraceuticals Ltd (http://www.memoryaid.com/) For further information: Percy Lomax ReGen Therapeutics Plc Tel No 020 7153 4920 Roland Cornish/Felicity Geidt Beaumont Cornish Limited Tel No 020 7628 3396 Nick Bealer/David Scott Alexander David Tel No 020 7448 9820 [HUG#1434598] This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that: (i) the releases contained herein are protected by copyright and other applicable laws; and (ii) they are solely responsible for the content, accuracy and originality of the information contained therein. Source: ReGen Therapeutics Plc via Thomson Reuters ONE
1 Year Argent Biopharma Chart |
1 Month Argent Biopharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions